Gastroesophageal Reflux Disease Clinical Trial
— GERDOfficial title:
Effects of Diaphragmatic Myofascial Release in Gastroesophageal Reflux Disease
NCT number | NCT03299985 |
Other study ID # | JParraga |
Secondary ID | |
Status | Completed |
Phase | N/A |
First received | |
Last updated | |
Start date | October 5, 2017 |
Est. completion date | March 15, 2018 |
Verified date | October 2018 |
Source | Cardenal Herrera University |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
This study is a double blinded randomized clinical trial with two arms which aims to study
the effects of diaphragmatic myofascial release in patients with gastroesophageal reflux
disease (GERD).
GERD has become in the last decades a common disease at the occidental world affecting
between 10 to 15% of this population. That implies a high socio-health cost and the decline
of the quality of life of those patients.
The diaphragm muscle surrounds the lower esophageal sphincter, and helps to prevent
gastroesophageal reflux. If one or both structures become incompetent, it may appear GERD.
Until the moment, the treatment for GERD begins by lifestyle modification, and if it fails,
the treatment becomes medical and, in selected cases, surgical.
It exists some studies that have demonstrate that diaphragmatic breathing training can have a
positive effect in GERD and the need of drug usage. But until the moment, the effects of a
myofascial release of the diaphragm haven't been explored on these patients.
Thirty patients with GERD referred from different hospitals of Valencia will be randomized
into two groups:
- Intervention with myofascial release for the diaphragm
- Sham treatment group which is going to receive the same number of session treatments
with the same manual techniques, but without the myofascial stimulus The protocol that
will be applied consists of 4 identical sessions of myofascial release techniques aimed
to normalize the myofascial tension of the diaphragmatic muscle. These sessions will be
distributed in two weeks.
The study focuses on the analysis of the following variables:
- Frequency and intensity of the symptoms of GERD: Reflux Disease Questionnaire (RDQ)
- Specific quality of life for gastrointestinal disease: Gastrointestinal Quality of life
Index (GIQLI)
- Drug usage: weekly milligrams usage of proton pomp inhibitors (PPI) The results of these
pre-intervention and post-intervention variables will be compared between the two groups
at baseline (first session), at week 3 and at week 6.
Status | Completed |
Enrollment | 30 |
Est. completion date | March 15, 2018 |
Est. primary completion date | March 15, 2018 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years to 70 Years |
Eligibility |
Inclusion Criteria: - Patients with the diagnostic of GERD Exclusion Criteria: - hiatal hernia >2 cm - previous operation at the LES - actual erosive esophagitis - Congenital or acquired immune disorders. - Allergic status of any kind. - Systemic diseases (rheumatic, infectious conditions, febrile state, vascular alterations, endocrine including diabetes, metabolic and neoplastic). - Leukemia. - Severe psychiatric disorders. - Neuromuscular or neurological injuries. - Aneurysms. - Abdominal or spine surgery. - Vertebral fractures. - Osteoporosis (advanced stage). - Acute lesions of soft tissues or in an inflammatory state. - Open wounds. - Pregnancy. - Intrauterine device. - Patients with corticosteroid therapy. - Hemophilia or treatment with anticoagulant therapy. - Hypersensitivity of the skin or dermatological diseases in the trunk that impossibilities the application of the techniques. - Rejection of manual contact. - Non-Spanish speaking patients. - Patients who have previously received some treatment of myofascial release. |
Country | Name | City | State |
---|---|---|---|
Spain | Universidad CEU Cardenal Herrera | Valencia |
Lead Sponsor | Collaborator |
---|---|
Cardenal Herrera University |
Spain,
Arguisuelas MD, Lisón JF, Sánchez-Zuriaga D, Martínez-Hurtado I, Doménech-Fernández J. Effects of Myofascial Release in Nonspecific Chronic Low Back Pain: A Randomized Clinical Trial. Spine (Phila Pa 1976). 2017 May 1;42(9):627-634. doi: 10.1097/BRS.00000 — View Citation
da Silva RC, de Sá CC, Pascual-Vaca ÁO, de Souza Fontes LH, Herbella Fernandes FA, Dib RA, Blanco CR, Queiroz RA, Navarro-Rodriguez T. Increase of lower esophageal sphincter pressure after osteopathic intervention on the diaphragm in patients with gastroe — View Citation
Eherer AJ, Netolitzky F, Högenauer C, Puschnig G, Hinterleitner TA, Scheidl S, Kraxner W, Krejs GJ, Hoffmann KM. Positive effect of abdominal breathing exercise on gastroesophageal reflux disease: a randomized, controlled study. Am J Gastroenterol. 2012 M — View Citation
Eypasch E, Williams JI, Wood-Dauphinee S, Ure BM, Schmülling C, Neugebauer E, Troidl H. Gastrointestinal Quality of Life Index: development, validation and application of a new instrument. Br J Surg. 1995 Feb;82(2):216-22. — View Citation
Nuevo J, Tafalla M, Zapardiel J. [Validation of the Reflux Disease Questionnaire (RDQ) and Gastrointestinal Impact Scale (GIS) in patients with gastroesophageal reflux disease in the Spanish population]. Gastroenterol Hepatol. 2009 Apr;32(4):264-73. doi: 10.1016/j.gastrohep.2008.12.004. Epub 2009 Apr 16. Spanish. — View Citation
Quintana JM, Cabriada J, López de Tejada I, Varona M, Oribe V, Barrios B, Perdigo L, Bilbao A. Translation and validation of the gastrointestinal Quality of Life Index (GIQLI). Rev Esp Enferm Dig. 2001 Nov;93(11):693-706. English, Spanish. — View Citation
Shaw M, Dent J, Beebe T, Junghard O, Wiklund I, Lind T, Johnsson F. The Reflux Disease Questionnaire: a measure for assessment of treatment response in clinical trials. Health Qual Life Outcomes. 2008 Apr 30;6:31. doi: 10.1186/1477-7525-6-31. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | GERD symptoms | Frequency and intensity of GERD symptoms measured by the Reflux Disease questionnaire (RDQ) | 6 weeks | |
Secondary | Specific quality of life for gastrointestinal disease | Gastrointestinal Quality of life Index (GIQLI) | 6 weeks | |
Secondary | Drug Usage | Weekly milligrams usage of proton pomp inhibitors (PPI) | 6 weeks |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02135107 -
A Double-blind Comparative Study of the Efficacy and Safety of E3810 10mg Once and Twice Daily in Maintenance Therapy for PPI Resistant Gastroesophageal Reflux Disease Patients
|
Phase 3 | |
Completed |
NCT01432392 -
Symptom Control and Impact on Daily Life in Patients With Gastroesophageal Reflux Disease
|
N/A | |
Recruiting |
NCT01249482 -
Symptom Assessment for GERD Patients Receiving H. Pylori Eradication
|
N/A | |
Completed |
NCT01200550 -
The Study to Describe Symptom Control and Impact on Daily Life in Gastroesophageal Reflux Disease (GERD) Patients
|
N/A | |
Completed |
NCT01578642 -
Feasibility Study for Evaluating the Effect of Electrical Stimulation on Lower Esophageal Sphincter Pressure and Esophageal Acid Exposure in Patients With Gastroesophageal Reflux Disease
|
Phase 2 | |
Unknown status |
NCT01128608 -
The Effect of High PCO2 Solution on Esophageal Acid Sensation
|
N/A | |
Completed |
NCT00978016 -
A Study to Evaluate the Efficacy and Safety of Arbaclofen Placarbil (XP19986) as Adjunctive Therapy in Subjects With Gastroesophageal Reflux Disease (GERD)
|
Phase 2 | |
Completed |
NCT00998244 -
Study to Evaluate the Effect of a Very Low Carbohydrate Diet on Gastroesophageal Reflux Disease
|
N/A | |
Completed |
NCT00768196 -
Prevalence of EED and Quality of Life Evaluated by Gastroesophageal Reflux Disease (GERD)-Q in Korean GERD Patients
|
N/A | |
Completed |
NCT00768443 -
Symptoms and Management Strategies in Gastroesophageal Reflux Disease (GERD)
|
N/A | |
Recruiting |
NCT00498082 -
Determinants of Efficacy of EsophyX Treatment in Gastro-Esophageal Reflux Disease
|
N/A | |
Completed |
NCT00886197 -
Diagnostic Efficacy of Narrow Band Imaging in Patients With Gastroesophageal Reflux Disease
|
N/A | |
Completed |
NCT00378898 -
Feasibility of Placing Bravo PH Capsule in Proximal Esophagus
|
N/A | |
Completed |
NCT00217347 -
Evaluation of Efficiency of Esophageal Capsule Endoscopy in the Screening of Patients With Gastroesophageal Reflux Disease or Dyspepsia as Compared to Upper Endoscopy
|
N/A | |
Completed |
NCT00507377 -
Foreshortened Esophagus and Its Surgical Therapy
|
||
Completed |
NCT00165022 -
Development of a Novel Disease-Specific Quality of Life Questionnaire for Gastroesophageal Reflux Disease (GERD) Patients in Chinese Population
|
N/A | |
Completed |
NCT00625495 -
Study Comparing the Effects of Esomeprazole Adminstered Orally and Intravenously on Basal and Pentrigastrin-stimulated Acid Output in Subjects With Symptoms of Gastroesophageal Reflux Disease (GERD)
|
Phase 4 | |
Completed |
NCT00214552 -
Evaluate the Effects on Asthma Control of Rabeprazole Given Twice Daily in Subjects With Asthma.
|
Phase 3 | |
Completed |
NCT00618150 -
Patient Education in Gastroesophageal Reflux Disease
|
N/A | |
Completed |
NCT03284177 -
A Trial of C13-CAC Breath Test in PPI Resistant GERD Patients
|
Phase 2 |